CL2007003765A1 - COMPOUNDS DERIVED FROM 2-OXO-4-HIDROXI-BENZOTIAZOL; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS COPD, BRONCHITIS, ASTHMA AND BRONCHIECTASIES. - Google Patents

COMPOUNDS DERIVED FROM 2-OXO-4-HIDROXI-BENZOTIAZOL; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS COPD, BRONCHITIS, ASTHMA AND BRONCHIECTASIES.

Info

Publication number: CL2007003765A1
Authority: CL; Chile
Prior art keywords: bronchiectasies; benzotiazol; hidroxi; copd; bronchitis
Prior art date: 2006-12-20

Application number

CL200703765A

Other languages

Spanish (es)

Inventor

Stephen Humphries Ale Connolly

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-20

Filing date

2007-12-20

Publication date

2008-08-22

2007-12-20 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2008-08-22 Publication of CL2007003765A1 publication Critical patent/CL2007003765A1/en

Links

208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 title 1
208000006673 asthma Diseases 0.000 title 1
206010006451 bronchitis Diseases 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
238000002360 preparation method Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)

CL200703765A 2006-12-20 2007-12-20 COMPOUNDS DERIVED FROM 2-OXO-4-HIDROXI-BENZOTIAZOL; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS COPD, BRONCHITIS, ASTHMA AND BRONCHIECTASIES. CL2007003765A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US87092206P	2006-12-20	2006-12-20
US91004507P	2007-04-04	2007-04-04
US95198007P	2007-07-26	2007-07-26

Publications (1)

Publication Number	Publication Date
CL2007003765A1 true CL2007003765A1 (en)	2008-08-22

Family

ID=39167020

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200703765A CL2007003765A1 (en)	2006-12-20	2007-12-20	COMPOUNDS DERIVED FROM 2-OXO-4-HIDROXI-BENZOTIAZOL; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS COPD, BRONCHITIS, ASTHMA AND BRONCHIECTASIES.

Country Status (21)

Country	Link
US (3)	US7700782B2 (en)
EP (1)	EP2121642B1 (en)
JP (1)	JP2010513440A (en)
KR (1)	KR20090091342A (en)
AR (1)	AR064635A1 (en)
AT (1)	ATE517879T1 (en)
AU (1)	AU2007336075B2 (en)
BR (1)	BRPI0722096A2 (en)
CA (1)	CA2672811A1 (en)
CL (1)	CL2007003765A1 (en)
CO (1)	CO6190554A2 (en)
EC (1)	ECSP099426A (en)
HK (1)	HK1136572A1 (en)
IL (1)	IL199014A0 (en)
MX (1)	MX2009006009A (en)
NO (1)	NO20092691L (en)
PE (1)	PE20081544A1 (en)
SA (1)	SA07280728B1 (en)
TW (1)	TW200833670A (en)
UY (1)	UY30808A1 (en)
WO (1)	WO2008075026A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200738658A (en) *	2005-08-09	2007-10-16	Astrazeneca Ab	Novel compounds
TW200738659A (en) *	2005-08-29	2007-10-16	Astrazeneca Ab	Novel compounds
TW200745067A (en) *	2006-03-14	2007-12-16	Astrazeneca Ab	Novel compounds
TW200825084A (en)	2006-11-14	2008-06-16	Astrazeneca Ab	New compounds 521
TW200833670A (en) *	2006-12-20	2008-08-16	Astrazeneca Ab	Novel compounds 569
GB0702458D0 (en) *	2007-02-08	2007-03-21	Astrazeneca Ab	Salts 668
CN102088976B (en) *	2008-05-13	2012-12-26	阿斯利康(瑞典)有限公司	Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist
EA017627B1 (en)	2008-05-13	2013-01-30	Астразенека Аб	Quinuclidine derivatives as muscarinic m3 receptor antagonists
AU2009260899B2 (en)	2008-06-18	2012-02-23	Astrazeneca Ab	Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
KR20110022611A (en) *	2008-06-20	2011-03-07	아스트라제네카 아베	Pharmaceutical composition comprising 4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl compound for the regulation of beta-2-adrenergic receptor activity
GB0814728D0 (en) *	2008-08-12	2008-09-17	Argenta Discovery Ltd	New combination
TW201036957A (en)	2009-02-20	2010-10-16	Astrazeneca Ab	Novel salt 628
GB0913342D0 (en)	2009-07-31	2009-09-16	Astrazeneca Ab	Compounds - 801
WO2011061527A1 (en)	2009-11-17	2011-05-26	Astrazeneca Ab	Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
GB201016912D0 (en)	2010-10-07	2010-11-24	Astrazeneca Ab	Novel combination
JO3192B1 (en)	2011-09-06	2018-03-08	Novartis Ag	Benzothiazolone compound
WO2015050984A1 (en) *	2013-10-01	2015-04-09	New York University	Amino, amido, and heterocyclic compounds as modulators of rage activity and uses thereof

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2653977A (en) *		1953-09-29		Chxnx
US3775477A (en) *	1971-03-10	1973-11-27	Sterling Drug Inc	N,n'-bis(2-aryl-2-(hydroxy or oxo)-ethyl)-bridged-bis-carboxamides
US4460581A (en) *	1982-10-12	1984-07-17	Boehringer Ingelheim Kg	(1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE3571808D1 (en)	1984-04-17	1989-08-31	Glaxo Group Ltd	Ethanolamine compounds
US4554284A (en)	1984-09-12	1985-11-19	Smithkline Beckman Corporation	7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
US4554287A (en)	1984-09-12	1985-11-19	Smithkline Beckman Corporation	Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
GB8525483D0 (en)	1985-10-16	1985-11-20	Glaxo Group Ltd	Chemical compounds
GB8718938D0 (en)	1987-08-11	1987-09-16	Glaxo Group Ltd	Chemical compounds
EP0422889A3 (en)	1989-10-10	1991-08-28	Glaxo Group Limited	Phenethanolamine compounds
GB9210632D0 (en)	1992-05-19	1992-07-01	Fisons Plc	Compounds
US5648370A (en) *	1990-11-20	1997-07-15	Astra Pharmaceuticals Limited	7-(2-aminoethyl) benzothiazolones
GB9211172D0 (en)	1992-05-27	1992-07-08	Fisons Plc	Compounds
IE914003A1 (en)	1990-11-20	1992-05-20	Astra Pharma Prod	Biologically Active Amines
TW356468B (en) *	1995-09-15	1999-04-21	Astra Pharma Prod	Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
GB9526511D0 (en)	1995-12-23	1996-02-28	Astra Pharma Prod	Pharmaceutically active compounds
DE69709647T2 (en)	1996-05-20	2002-11-07	Dupont Pharmaceuticals Research Laboratories, Inc.	CYCLIC DIARYLALKYL DIAMINE DERIVATIVES AS AN ANTOGONISTS OF CHEMOKINE RECEPTORS
SE9700706D0 (en)	1997-02-27	1997-02-27	Astra Pharma Prod	Process for the preparation of benzothiazoline compounds
SE9701304D0 (en)	1997-04-09	1997-04-09	Astra Pharma Prod	Compounds
EP1075278A1 (en)	1998-01-13	2001-02-14	AstraZeneca UK Limited	PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND HAVING DOPAMINE (D 2?) RECEPTOR AGONIST ACTIVITY AND A COMPOUND (B) HAVING $g(b) 2?-ADRENORECEPTOR AGONIST ACTIVITY
US6541669B1 (en)	1998-06-08	2003-04-01	Theravance, Inc.	β2-adrenergic receptor agonists
GB9913083D0 (en)	1999-06-04	1999-08-04	Novartis Ag	Organic compounds
US6683115B2 (en) *	1999-06-02	2004-01-27	Theravance, Inc.	β2-adrenergic receptor agonists
SE9902937D0 (en)	1999-08-18	1999-08-18	Astra Pharma Prod	Pharmaceutical compositions
SE9902936D0 (en)	1999-08-18	1999-08-18	Astra Pharma Prod	Pharmaceutical compositions
SE9902938D0 (en)	1999-08-18	1999-08-18	Astra Pharma Prod	Pharmaceutical compositions
SE9902935D0 (en)	1999-08-18	1999-08-18	Astra Pharma Prod	Pharmaceutical compositions
OA11558A (en)	1999-12-08	2004-06-03	Advanced Medicine Inc	Beta 2-adrenergic receptor agonists.
US6506901B2 (en)	2000-07-17	2003-01-14	Wyeth	Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine β-3 adrenergic receptor agonists
US7045658B2 (en)	2001-03-22	2006-05-16	Glaxo Group Limited	Formailide derivatives as beta2-adrenoreceptor agonists
KR100912324B1 (en)	2001-09-14	2009-08-14	글락소 그룹 리미티드	Penethanolamine Derivatives for the Treatment of Respiratory Diseases
US20030229058A1 (en) *	2001-11-13	2003-12-11	Moran Edmund J.	Aryl aniline beta2 adrenergic receptor agonists
GB0217225D0 (en)	2002-07-25	2002-09-04	Glaxo Group Ltd	Medicinal compounds
AR040962A1 (en) *	2002-08-09	2005-04-27	Novartis Ag	COMPOUNDS DERIVED FROM TIAZOL 1,3-2-ONA, PHARMACEUTICAL COMPOSITION AND COMPOSITE PREPARATION PROCESS
GB0225540D0 (en)	2002-11-01	2002-12-11	Glaxo Group Ltd	Medicinal compounds
PE20040950A1 (en)	2003-02-14	2005-01-01	Theravance Inc	BIPHENYL DERIVATIVES AS AGONISTS OF ß2-ADRENERGIC RECEPTORS AND AS ANTAGONISTS OF MUSCARINAL RECEPTORS
GB0303396D0 (en)	2003-02-14	2003-03-19	Glaxo Group Ltd	Medicinal compounds
EP1615881A2 (en)	2003-04-01	2006-01-18	Theravance, Inc.	Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TW200526547A (en)	2003-09-22	2005-08-16	Theravance Inc	Amino-substituted ethylamino β2 adrenergic receptor agonists
GB0324654D0 (en)	2003-10-22	2003-11-26	Glaxo Group Ltd	Medicinal compounds
GB0324886D0 (en)	2003-10-24	2003-11-26	Glaxo Group Ltd	Medicinal compounds
JP2005187357A (en)	2003-12-25	2005-07-14	Nippon Suisan Kaisha Ltd	METHOD FOR PRODUCING BENZOTHIAZOLONE DERIVATIVE HAVING SELECTIVE beta2-RECEPTOR AGONIST ACTIVITY
TW200531692A (en)	2004-01-12	2005-10-01	Theravance Inc	Aryl aniline derivatives as β2 adrenergic receptor agonists
GB0402797D0 (en)	2004-02-09	2004-03-10	Novartis Ag	Organic compounds
WO2005092861A1 (en)	2004-03-11	2005-10-06	Pfizer Limited	Quinolinone derivatives pharmaceutical compositions containing them and their use
EP1577306A1 (en)	2004-03-17	2005-09-21	Boehringer Ingelheim Pharma GmbH & Co.KG	novel benzoxazinone derivatives as slow-acting betamimetics and use thereof in treatment of respiratory tract diseases
WO2005092841A1 (en)	2004-03-23	2005-10-06	Pfizer Limited	Compounds having beta-agonist activity
JP2007537187A (en)	2004-05-13	2007-12-20	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Hydroxy-substituted benzofused heterocyclic compounds for use as beta agonists in the treatment of respiratory diseases
EP1595873A1 (en)	2004-05-13	2005-11-16	Boehringer Ingelheim Pharma GmbH & Co.KG	Substituted cycloalkyl derivatives for the treatment of respiratory diseases
DE102004024453A1 (en)	2004-05-14	2006-01-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New long-acting bronchodilators for the treatment of respiratory diseases
US20080039495A1 (en)	2004-06-03	2008-02-14	Linsell Martin S	Diamine Beta2 Adrenergic Receptor Agonists
EP1778638A1 (en)	2004-07-21	2007-05-02	Theravance, Inc.	Diaryl ether beta2 adrenergic receptor agonists
EP1778626A1 (en)	2004-08-16	2007-05-02	Theravance, Inc.	Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
WO2006023460A2 (en)	2004-08-16	2006-03-02	Theravance, Inc.	COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
US7566785B2 (en)	2004-09-10	2009-07-28	Theravance, Inc.	Amidine substituted aryl aniline compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
WO2006074897A1 (en)	2005-01-11	2006-07-20	Glaxo Group Limited	Cinnamate salts of a beta-2 adrenergic agonist
GB0511066D0 (en)	2005-05-31	2005-07-06	Novartis Ag	Organic compounds
CA2614757C (en)	2005-07-18	2011-11-08	Pfizer Limited	Process for the preparation of sulfonamide derivatives
TW200738658A (en) *	2005-08-09	2007-10-16	Astrazeneca Ab	Novel compounds
TW200740781A (en)	2005-08-29	2007-11-01	Astrazeneca Ab	Novel compounds
TW200738659A (en) *	2005-08-29	2007-10-16	Astrazeneca Ab	Novel compounds
US20090029958A1 (en) *	2006-03-08	2009-01-29	Lilian Alcaraz	Phenethanolamine derivatives as beta2 adrenoreceptor agonists
TW200745084A (en)	2006-03-08	2007-12-16	Astrazeneca Ab	Novel compounds
TW200745067A (en)	2006-03-14	2007-12-16	Astrazeneca Ab	Novel compounds
WO2008041914A1 (en)	2006-10-06	2008-04-10	Astrazeneca Ab	5-(2-AMINO-L-HYDROXYETHYL)-8-HYDROXY-2-OXOQUINOLINE DERIVATIVES AND OTHER COMPOUNDS AS β2 -ADRENERGIC AGONISTS
TW200833670A (en)	2006-12-20	2008-08-16	Astrazeneca Ab	Novel compounds 569
US20120142646A1 (en)	2006-12-20	2012-06-07	Lilian Alcaraz	Novel Compounds 621
GB0702456D0 (en)	2007-02-08	2007-03-21	Astrazeneca Ab	New combination
GB0702458D0 (en) *	2007-02-08	2007-03-21	Astrazeneca Ab	Salts 668
GB0702457D0 (en)	2007-02-08	2007-03-21	Astrazeneca Ab	New combination 666
GB0702459D0 (en)	2007-02-08	2007-03-21	Astrazeneca Ab	Salts 669
GB0703999D0 (en)	2007-03-01	2007-04-11	Astrazeneca Ab	New combination 667
GB0704000D0 (en)	2007-03-01	2007-04-11	Astrazeneca Ab	Salts 670
WO2009037503A2 (en)	2007-09-18	2009-03-26	Astrazeneca Ab	New combination - 012 for the treatment of respiratory diseases
JP5646341B2 (en) *	2007-12-20	2014-12-24	アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａＡｋｔｉｅｂｏｌａｇ	Dosage device and method for mixing powder in airflow 537
KR20110022611A (en) *	2008-06-20	2011-03-07	아스트라제네카 아베	Pharmaceutical composition comprising 4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl compound for the regulation of beta-2-adrenergic receptor activity

2007
- 2007-12-07 TW TW096146813A patent/TW200833670A/en unknown
- 2007-12-19 WO PCT/GB2007/004861 patent/WO2008075026A1/en active Application Filing
- 2007-12-19 US US11/959,679 patent/US7700782B2/en not_active Expired - Fee Related
- 2007-12-19 JP JP2009542202A patent/JP2010513440A/en active Pending
- 2007-12-19 UY UY30808A patent/UY30808A1/en unknown
- 2007-12-19 BR BRPI0722096-0A2A patent/BRPI0722096A2/en not_active IP Right Cessation
- 2007-12-19 AU AU2007336075A patent/AU2007336075B2/en not_active Ceased
- 2007-12-19 AT AT07848598T patent/ATE517879T1/en not_active IP Right Cessation
- 2007-12-19 US US12/519,552 patent/US20100022491A1/en not_active Abandoned
- 2007-12-19 MX MX2009006009A patent/MX2009006009A/en active IP Right Grant
- 2007-12-19 CA CA002672811A patent/CA2672811A1/en not_active Abandoned
- 2007-12-19 KR KR1020097015062A patent/KR20090091342A/en not_active Withdrawn
- 2007-12-19 EP EP07848598A patent/EP2121642B1/en active Active
- 2007-12-20 AR ARP070105801A patent/AR064635A1/en not_active Application Discontinuation
- 2007-12-20 CL CL200703765A patent/CL2007003765A1/en unknown
- 2007-12-29 SA SA7280728A patent/SA07280728B1/en unknown
2008
- 2008-01-02 PE PE2008000009A patent/PE20081544A1/en not_active Application Discontinuation
2009
- 2009-05-27 CO CO09054440A patent/CO6190554A2/en not_active Application Discontinuation
- 2009-05-27 IL IL199014A patent/IL199014A0/en unknown
- 2009-06-15 EC EC2009009426A patent/ECSP099426A/en unknown
- 2009-07-15 NO NO20092691A patent/NO20092691L/en not_active Application Discontinuation
2010
- 2010-03-30 US US12/750,014 patent/US20100249200A1/en not_active Abandoned
- 2010-04-24 HK HK10104038.4A patent/HK1136572A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP2121642A1 (en)	2009-11-25
PE20081544A1 (en)	2009-01-11
CA2672811A1 (en)	2008-06-26
US20100249200A1 (en)	2010-09-30
BRPI0722096A2 (en)	2014-04-01
NO20092691L (en)	2009-09-16
US20100022491A1 (en)	2010-01-28
US7700782B2 (en)	2010-04-20
SA07280728B1 (en)	2010-12-01
US20080207698A1 (en)	2008-08-28
IL199014A0 (en)	2010-02-17
AU2007336075A1 (en)	2008-06-26
WO2008075026A1 (en)	2008-06-26
ECSP099426A (en)	2009-07-31
ATE517879T1 (en)	2011-08-15
TW200833670A (en)	2008-08-16
HK1136572A1 (en)	2010-07-02
AU2007336075B2 (en)	2011-10-27
MX2009006009A (en)	2009-06-16
KR20090091342A (en)	2009-08-27
CO6190554A2 (en)	2010-08-19
AR064635A1 (en)	2009-04-15
JP2010513440A (en)	2010-04-30
EP2121642B1 (en)	2011-07-27
UY30808A1 (en)	2008-07-31

Similar Documents

Publication	Publication Date	Title
CL2007003765A1 (en)	2008-08-22	COMPOUNDS DERIVED FROM 2-OXO-4-HIDROXI-BENZOTIAZOL; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS COPD, BRONCHITIS, ASTHMA AND BRONCHIECTASIES.
CL2008000307A1 (en)	2008-05-30	COMPOUNDS DERIVED FROM CHROMEN-2-ONA REPLACED; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF SUCH DISEASES AS ATEROSCLEROSIS, ASTHMA, ALLERGIC RHINITIS AND COPD.
CL2007002099A1 (en)	2008-02-22	COMPOUNDS DERIVED FROM 3H-ESPIRO (1-BENZOFURAN-2,4'-PIPERIDINA); PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF RESPIRATORY DISEASES, SUCH AS COPD AND ASTHMA.
CL2008000434A1 (en)	2008-08-22	COMPOUNDS DERIVED FROM 2-AMINO-OXAZOLINAS; OBTAINING PROCESS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DEPRESSION, ANXIETY, STRESS, BIPOLAR DISORDER, AMONG OTHERS.
CL2008000690A1 (en)	2008-09-12	COMPOUNDS DERIVED FROM INDOL-3-PROPIONIC ACID; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS HYPERLIPIDEMIA, HYPERTENSION; AMONG OTHER.
CL2007002274A1 (en)	2008-04-18	COMPOUNDS DERIVED FROM ACID (3-AMINO-1,2,3,4-TETRAHIDRO-9H-CARBAZOL-9-IL) -ACETICO; PHARMACEUTICAL COMPOSITION; AND USE FOR THE PREVENTION AND / OR TREATMENT OF ALLERGIC AND IMMUNE DISEASES, SUCH AS ASTHMA, COPD AND RHINITIS AMONG OTHERS.
CL2007000806A1 (en)	2008-05-30	COMPOUNDS DERIVED FROM REPLACED HETEROPENTACICLOS; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER.
CL2008001304A1 (en)	2008-09-22	COMPOUNDS DERIVED FROM REPLACED INDOL, INHIBITORS OF THE 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP); PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF SUCH DISEASES AS COPD, CARDIOVASCULAR DISEASE AND INFLAMMATION.
CL2007002610A1 (en)	2008-02-01	COMPOUNDS DERIVED FROM REPLACED BIPIRIDINE; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND / OR PROFILAXIS OF DISEASES SUCH AS HYPERTONIA, DIABETES, MYOCARDIAL INFARTS, BETWEEN OTHERS.
CL2008003694A1 (en)	2010-01-15	Compounds derived from substituted heterocycle-2-carboxamide; pharmaceutical composition; pharmaceutical combination; and its use as inhibitors of dipeptidyl peptidase iv (dpp-iv) in the treatment of asthma, copd and allergic rhinitis.
CL2007000161A1 (en)	2008-05-30	COMPOUNDS DERIVED FROM SUBSTITUTED 2,4-DIOXOIMIDAZOLIDINE, INHIBITORS OF KINE PROTEINS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS CANCER.
CL2007002708A1 (en)	2008-04-04	COMPOUNDS DERIVED FROM PIRROLO [2,3-B] PIRIDINA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS CANCER, CAQUEXY, INFLAMMATORY DISORDERS, AMONG OTHERS.
CL2007002377A1 (en)	2008-04-04	COMPOUNDS DERIVED FROM QUINAZOLINA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE AS ANTICANCERIGENO.
CL2007003754A1 (en)	2008-08-22	COMPOUNDS DERIVED FROM ARIL (HETEROARIL) ALQUIL-AMINA; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS BRONCHITIS, PULMONARY DISEASE AND COPD.
CL2007003804A1 (en)	2008-08-22	COMPOUNDS DERIVED FROM INDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT INFLAMMATORY CONDITIONS, SUCH AS ASTHMA, COPD.
CL2007003879A1 (en)	2008-07-04	COMPOUNDS DERIVED FROM ARIL-CARBOXAMIDA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS ALZHEIMER, EPILEPSY AND PARKINSON.
CL2008000531A1 (en)	2008-09-22	COMPOUNDS DERIVED FROM HETEROCICLES, INHIBITORS OF ASPARTILPROTEASA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE IN THE TREATMENT OF CARDIOVASCULAR, COGNITIVE AND NEURODEGENERATIVE DISEASES SUCH AS THE DISEASE
CL2007003635A1 (en)	2008-08-22	COMPOUNDS DERIVED FROM 6-AMINO-PURIN-8-ONA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PROCESS TO PREPARE PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF ALLERGIC, VIRAL OR CANCER DISEASES.
CL2007002121A1 (en)	2008-02-22	COMPOUNDS DERIVED FROM PIRAZOLES, GLUCOQUINASA ACTIVATORS; PREPARATION PROCESS OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND USE FOR THE TREATMENT OF DISEASES AND / OR METABOLIC DISORDERS, AS DIAB
CL2007002593A1 (en)	2008-06-13	COMPOUNDS DERIVED FROM 4-HETEROARIL-PIRIDINA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF SUCH DISEASES AS REJECTION OF TRANSPLANTED ORGANS, AUTOIMMUNE SYNDROMES AND CANCER.
CL2012001464A1 (en)	2014-03-07	Compounds derived from (2-amino-5,5-difluor-5,6-dihydro-4h- [1,3] oxazin-4-yl) -phenylamide, bace1 and / or bace2 inhibitors; pharmaceutical composition; preparation procedure; and use in the therapeutic and / or prophylactic treatment of diseases such as Alzheimer's and diabetes.
CL2007002996A1 (en)	2008-06-13	COMPOUNDS DERIVED FROM REPLACED QUINOLINE, MODULATORS OF LIVER X RECEPTORS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF SUCH DISEASES AS ACUTE CORONARY SYNDROME, ALZHEIMER, DIABETES AND ATEROSCLEROSIS.
CL2008001994A1 (en)	2008-09-22	COMPOUNDS DERIVED FROM PIRAZIN-2-ONA; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, ATEROSCLEROSIS, HYPERTENSION, AMONG OTHERS.
CL2007001481A1 (en)	2008-05-09	COMPOUNDS DERIVED FROM REPLACED PIRROLIDINE, INHIBITORS OF PROTEASA ACTIVADORA DE CANAL; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF SUCH DISEASES AS CHYSTIC FIBROSIS, CHRONIC BRONCHITIS, COPD, ASTHMA AND VIAS R INFECTIONS
CL2007001976A1 (en)	2008-05-16	COMPOUNDS DERIVED FROM DIOXOALCANS AND DIOXOALKENS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT ASTHMA, TOS, PURITO, HYPERSENSITIVITY.